Da eliminationen af kontraststoffet hos patienter med alvorlig nedsat nyrefunktion sker langsommere, må fordelene afvejes nøje i forhold til risici i disse tilfælde.
Since contrast medium elimination is delayed in patients with severely impaired renal function, the benefits must be weighed very carefully against the risks in such cases.